Home/Rejuvenate Bio/Daniel Oliver, MBA

DO

Daniel Oliver, MBA

CEO, Co-Founder

Therapeutic Areas

Age-related Diseases Metabolic Disease Cardiovascular Disease Renal Disease

Rejuvenate Bio Pipeline

Drug	Indication	Phase
Canine Gene Therapy for MVD	Canine Mitral Valve Disease	Pre-clinical/Development
Human Combination Gene Therapy	Multiple Age-Related Diseases (e.g., metabolic, cardiovascular)	Pre-clinical

Leadership Team at Rejuvenate Bio

George Church, Ph.D.

Co-Founder and SAB Chair

Noah Davidsohn, Ph.D.

CSO, Co-Founder

Deborah Ascheim, M.D.

Chief Medical Officer

View full Rejuvenate Bio profile